Skip to main content
Top
Published in: European Journal of Trauma and Emergency Surgery 3/2022

18-09-2021 | Original Article

Optimal timing of venous thromboembolic chemoprophylaxis initiation following blunt solid organ injury: meta-analysis and systematic review

Authors: Patrick B. Murphy, Marc de Moya, Basil Karam, Laura Menard, Erik Holder, Kenji Inaba, Morgan Schellenberg

Published in: European Journal of Trauma and Emergency Surgery | Issue 3/2022

Login to get access

Abstract

Purpose

The need to prevent venous thromboembolism (VTE) following blunt solid organ injury must be balanced against the concern for exacerbation of hemorrhage. The optimal timing for initiation of VTE chemoprophylaxis is not known. The objective was to determine the safety and efficacy of early (≤ 48 h) VTE chemoprophylaxis initiation following blunt solid organ injury.

Methods

An electronic search was performed of medical libraries for English language studies on timing of VTE chemoprophylaxis initiation following blunt solid organ injury published from inception to April 2020. Included studies compared early (≤ 48 h) versus late (> 48 h) initiation of VTE chemoprophylaxis in adults with blunt splenic, liver, and/or kidney injury. Estimates were pooled using random-effects meta-analysis. Odds ratios were utilized to quantify differences in failure of nonoperative management, need for blood transfusion and rates of VTE.

Results

The search identified 2,111 studies. Of these, ten studies comprising 14,675 patients were included. All studies were non-randomized and only one was prospective. The overall odds of failure of nonoperative management were no different between early and late groups, OR 1.09 (95%CI 0.92–1.29). Similarly, there was no difference in the need for blood transfusion either during overall hospital stay, OR 0.91 (95%CI 0.70–1.18), or post prophylaxis initiation, OR 1.23 (95%CI 0.55–2.73). There were significantly lower odds of VTE when patients received early VTE chemoprophylaxis, OR 0.51 (95%CI 0.33–0.81).

Conclusions

Patients undergoing nonoperative management for blunt solid organ injury can be safely and effectively prescribed early VTE chemoprophylaxis. This results in significantly lower VTE rates without demonstrable harm.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mammen EF. Pathogenesis of Venous Thrombosis. Am Coll Chest Phys. 1992;102:640S-S644. Mammen EF. Pathogenesis of Venous Thrombosis. Am Coll Chest Phys. 1992;102:640S-S644.
2.
go back to reference Nathens AB, McMurray MK, Cuschieri J, Durr EA, Moore EE, Bankey PE, Freeman B, Harbrecht BG, Johnson JL, Minei JP, McKinley BA, Moore FA, Shapiro MB, West MA, Tompkins RG, Maier RV. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62(3):557–62.PubMed Nathens AB, McMurray MK, Cuschieri J, Durr EA, Moore EE, Bankey PE, Freeman B, Harbrecht BG, Johnson JL, Minei JP, McKinley BA, Moore FA, Shapiro MB, West MA, Tompkins RG, Maier RV. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma. 2007;62(3):557–62.PubMed
3.
go back to reference Schellenberg M, Inaba K, Biswas S, Heindel P, Benjamin E, Strumwasser A, et al. When is it safe to start VTE prophylaxis after blunt solid organ injury? a prospective study from a level I trauma center. World J Surg. 2019;43:2797–803.CrossRef Schellenberg M, Inaba K, Biswas S, Heindel P, Benjamin E, Strumwasser A, et al. When is it safe to start VTE prophylaxis after blunt solid organ injury? a prospective study from a level I trauma center. World J Surg. 2019;43:2797–803.CrossRef
4.
go back to reference Alejandro KV, Acosta JA, Rodríguez PA. Bleeding manifestations after early use of low-molecular-weight heparins in blunt splenic injuries. Am Surg. 2003;69:1006–9.PubMed Alejandro KV, Acosta JA, Rodríguez PA. Bleeding manifestations after early use of low-molecular-weight heparins in blunt splenic injuries. Am Surg. 2003;69:1006–9.PubMed
5.
go back to reference Eberle BM, Schnüriger B, Inaba K, Cestero R, Kobayashi L, Barmparas G, et al. Thromboembolic prophylaxis with low-molecular-weight heparin in patients with blunt solid abdominal organ injuries undergoing nonoperative management: current practice and outcomes. J Trauma. 2011;70:141–6.PubMed Eberle BM, Schnüriger B, Inaba K, Cestero R, Kobayashi L, Barmparas G, et al. Thromboembolic prophylaxis with low-molecular-weight heparin in patients with blunt solid abdominal organ injuries undergoing nonoperative management: current practice and outcomes. J Trauma. 2011;70:141–6.PubMed
6.
go back to reference Joseph B, Pandit V, Harrison C, Lubin D, Kulvatunyou N, Zangbar B, et al. Early thromboembolic prophylaxis in patients with blunt solid abdominal organ injuries undergoing nonoperative management: Is it safe? Am J Surg. 2015;209:194–8.CrossRef Joseph B, Pandit V, Harrison C, Lubin D, Kulvatunyou N, Zangbar B, et al. Early thromboembolic prophylaxis in patients with blunt solid abdominal organ injuries undergoing nonoperative management: Is it safe? Am J Surg. 2015;209:194–8.CrossRef
7.
go back to reference Khatsilouskaya T, Haltmeier T, Cathomas M, Eberle B, Candinas D, Schnüriger B. Thromboembolic prophylaxis with heparin in patients with blunt solid organ injuries undergoing non-operative treatment. World J Surg. 2017;41:1193–200.CrossRef Khatsilouskaya T, Haltmeier T, Cathomas M, Eberle B, Candinas D, Schnüriger B. Thromboembolic prophylaxis with heparin in patients with blunt solid organ injuries undergoing non-operative treatment. World J Surg. 2017;41:1193–200.CrossRef
8.
go back to reference Kwok AM, Davis JW, Dirks RC, Wolfe MM, Kaups KL. Time is now: venous thromboembolism prophylaxis in blunt splenic injury. Am J Surg. 2016;212:1231–6.CrossRef Kwok AM, Davis JW, Dirks RC, Wolfe MM, Kaups KL. Time is now: venous thromboembolism prophylaxis in blunt splenic injury. Am J Surg. 2016;212:1231–6.CrossRef
9.
go back to reference Lin B, Matsushima K, De Leon L, Piccinini A, Recinos G, Love B, et al. Early venous thromboembolism prophylaxis for isolated high-grade blunt splenic injury. J Surg Res. 2019;243:340–5.CrossRef Lin B, Matsushima K, De Leon L, Piccinini A, Recinos G, Love B, et al. Early venous thromboembolism prophylaxis for isolated high-grade blunt splenic injury. J Surg Res. 2019;243:340–5.CrossRef
10.
go back to reference Murphy PB, Sothilingam N, Stewart TC, Batey B, Moffat B, Gray DK, et al. Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe. Can J Surg. 2016;59:118–22.CrossRef Murphy PB, Sothilingam N, Stewart TC, Batey B, Moffat B, Gray DK, et al. Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safe. Can J Surg. 2016;59:118–22.CrossRef
11.
go back to reference Rostas JW, Manley J, Gonzalez RP, Brevard SB, Ahmed N, Frotan MA, et al. The safety of low molecular-weight heparin after blunt liver and spleen injuries. Am J Surg. 2015;210:31–4.CrossRef Rostas JW, Manley J, Gonzalez RP, Brevard SB, Ahmed N, Frotan MA, et al. The safety of low molecular-weight heparin after blunt liver and spleen injuries. Am J Surg. 2015;210:31–4.CrossRef
12.
go back to reference Skarupa D, Hanna K, Zeeshan M, Madbak F, Hamidi M, Haddadin Z, et al. Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision? J Trauma. 2019;87:1104–12.CrossRef Skarupa D, Hanna K, Zeeshan M, Madbak F, Hamidi M, Haddadin Z, et al. Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision? J Trauma. 2019;87:1104–12.CrossRef
13.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;21(339):b2700.CrossRef Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;21(339):b2700.CrossRef
15.
go back to reference Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRef Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRef
16.
go back to reference Chapman B, Moore E, Barnett C, Stovall R, Biffl W, Burley C, et al. Hypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulation. Am J Surg. 2013;206:917–23.CrossRef Chapman B, Moore E, Barnett C, Stovall R, Biffl W, Burley C, et al. Hypercoagulability following blunt solid abdominal organ injury: when to initiate anticoagulation. Am J Surg. 2013;206:917–23.CrossRef
17.
go back to reference Vogt K, Mahiri K, Murphy P, Parry N, Gray D, Moffat B, et al. The timing of initiation of venous thromboembolism prophylaxis after traumatic solid organ injury: a national survey of practice. Can J Surg. 2016;59:S30. Vogt K, Mahiri K, Murphy P, Parry N, Gray D, Moffat B, et al. The timing of initiation of venous thromboembolism prophylaxis after traumatic solid organ injury: a national survey of practice. Can J Surg. 2016;59:S30.
18.
go back to reference Zarzaur BL, Kozar RA, Fabian TC, Coimbra R. A survey of american association for the surgery of trauma member practices in the management of blunt splenic injury. J Trauma. 2011;70:1026–31.PubMed Zarzaur BL, Kozar RA, Fabian TC, Coimbra R. A survey of american association for the surgery of trauma member practices in the management of blunt splenic injury. J Trauma. 2011;70:1026–31.PubMed
19.
go back to reference Baltatzis M, Low R, Stathakis P, Sheen AJ, Siriwardena AK, Jamdar S. Efficacy and safety of pharmacological venous thromboembolism prophylaxis following liver resection: a systematic review and meta-analysis. HPB. 2017;19:289–96.CrossRef Baltatzis M, Low R, Stathakis P, Sheen AJ, Siriwardena AK, Jamdar S. Efficacy and safety of pharmacological venous thromboembolism prophylaxis following liver resection: a systematic review and meta-analysis. HPB. 2017;19:289–96.CrossRef
20.
go back to reference Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: A nested cohort study. Br J Anaesth. 2010;105:596–602.CrossRef Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: A nested cohort study. Br J Anaesth. 2010;105:596–602.CrossRef
21.
go back to reference Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group. J Trauma. 2002;53:142–64.CrossRef Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group. J Trauma. 2002;53:142–64.CrossRef
22.
go back to reference Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e419S-e496S.CrossRef Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e419S-e496S.CrossRef
23.
go back to reference Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, et al. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study. J Am Coll Surg. 2016;223:621–31.CrossRef Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, et al. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study. J Am Coll Surg. 2016;223:621–31.CrossRef
Metadata
Title
Optimal timing of venous thromboembolic chemoprophylaxis initiation following blunt solid organ injury: meta-analysis and systematic review
Authors
Patrick B. Murphy
Marc de Moya
Basil Karam
Laura Menard
Erik Holder
Kenji Inaba
Morgan Schellenberg
Publication date
18-09-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Trauma and Emergency Surgery / Issue 3/2022
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-021-01783-0

Other articles of this Issue 3/2022

European Journal of Trauma and Emergency Surgery 3/2022 Go to the issue